Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles

Antonio Di Martino, Pavel Kucharczyk, Zdenka Capakova, Petr Humpolicek, Vladimir Sedlarik

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In the presented work, amphiphilic nanoparticles based on chitosan and carboxy-enriched polylactic acid have been prepared to improve the stability of the pro-drug temozolomide in physiological media by encapsulation. The carrier, with a diameter in the range of 150–180 nm, was able to accommodate up to 800 μg of temozolomide per mg of polymer. The obtained formulation showed good stability in physiological condition and preparation media up to 1 month. Temozolomide loaded inside the carrier exhibited greater stability than the free drug, in particular in simulated physiological solution at pH 7.4 where the hydrolysis in the inactive metabolite was clearly delayed. CS-SPLA nanoparticles demonstrated a pH-dependent TMZ release kinetics with the opportunity to increase or decrease the rate. Mass spectroscopy, UV-Vis analysis, and in vitro cell tests confirmed the improvement in temozolomide stability and effectiveness when loaded into the polymeric carrier, in comparison with the free drug.

Original languageEnglish
Article number71
JournalJournal of Nanoparticle Research
Volume19
Issue number2
DOIs
Publication statusPublished - 1 Feb 2017
Externally publishedYes

Fingerprint

temozolomide
Chitosan
Nanoparticles
Enhancement
nanoparticles
Drugs
drugs
augmentation
Encapsulation
metabolites
Prodrugs
Metabolites
Ultraviolet spectroscopy
Pharmaceutical Preparations
hydrolysis
Spectroscopy
Hydrolysis
Preparation
Polymers
mass spectroscopy

Keywords

  • Chitosan
  • Drug delivery
  • Encapsulation
  • Nanomedicine
  • Nanoparticles
  • Polylactic acid
  • Temozolomide

ASJC Scopus subject areas

  • Bioengineering
  • Atomic and Molecular Physics, and Optics
  • Chemistry(all)
  • Modelling and Simulation
  • Materials Science(all)
  • Condensed Matter Physics

Cite this

Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles. / Di Martino, Antonio; Kucharczyk, Pavel; Capakova, Zdenka; Humpolicek, Petr; Sedlarik, Vladimir.

In: Journal of Nanoparticle Research, Vol. 19, No. 2, 71, 01.02.2017.

Research output: Contribution to journalArticle

Di Martino, Antonio ; Kucharczyk, Pavel ; Capakova, Zdenka ; Humpolicek, Petr ; Sedlarik, Vladimir. / Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles. In: Journal of Nanoparticle Research. 2017 ; Vol. 19, No. 2.
@article{606424fbfb3142a8bd520f120f1ed53a,
title = "Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles",
abstract = "In the presented work, amphiphilic nanoparticles based on chitosan and carboxy-enriched polylactic acid have been prepared to improve the stability of the pro-drug temozolomide in physiological media by encapsulation. The carrier, with a diameter in the range of 150–180 nm, was able to accommodate up to 800 μg of temozolomide per mg of polymer. The obtained formulation showed good stability in physiological condition and preparation media up to 1 month. Temozolomide loaded inside the carrier exhibited greater stability than the free drug, in particular in simulated physiological solution at pH 7.4 where the hydrolysis in the inactive metabolite was clearly delayed. CS-SPLA nanoparticles demonstrated a pH-dependent TMZ release kinetics with the opportunity to increase or decrease the rate. Mass spectroscopy, UV-Vis analysis, and in vitro cell tests confirmed the improvement in temozolomide stability and effectiveness when loaded into the polymeric carrier, in comparison with the free drug.",
keywords = "Chitosan, Drug delivery, Encapsulation, Nanomedicine, Nanoparticles, Polylactic acid, Temozolomide",
author = "{Di Martino}, Antonio and Pavel Kucharczyk and Zdenka Capakova and Petr Humpolicek and Vladimir Sedlarik",
year = "2017",
month = "2",
day = "1",
doi = "10.1007/s11051-017-3756-3",
language = "English",
volume = "19",
journal = "Journal of Nanoparticle Research",
issn = "1388-0764",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles

AU - Di Martino, Antonio

AU - Kucharczyk, Pavel

AU - Capakova, Zdenka

AU - Humpolicek, Petr

AU - Sedlarik, Vladimir

PY - 2017/2/1

Y1 - 2017/2/1

N2 - In the presented work, amphiphilic nanoparticles based on chitosan and carboxy-enriched polylactic acid have been prepared to improve the stability of the pro-drug temozolomide in physiological media by encapsulation. The carrier, with a diameter in the range of 150–180 nm, was able to accommodate up to 800 μg of temozolomide per mg of polymer. The obtained formulation showed good stability in physiological condition and preparation media up to 1 month. Temozolomide loaded inside the carrier exhibited greater stability than the free drug, in particular in simulated physiological solution at pH 7.4 where the hydrolysis in the inactive metabolite was clearly delayed. CS-SPLA nanoparticles demonstrated a pH-dependent TMZ release kinetics with the opportunity to increase or decrease the rate. Mass spectroscopy, UV-Vis analysis, and in vitro cell tests confirmed the improvement in temozolomide stability and effectiveness when loaded into the polymeric carrier, in comparison with the free drug.

AB - In the presented work, amphiphilic nanoparticles based on chitosan and carboxy-enriched polylactic acid have been prepared to improve the stability of the pro-drug temozolomide in physiological media by encapsulation. The carrier, with a diameter in the range of 150–180 nm, was able to accommodate up to 800 μg of temozolomide per mg of polymer. The obtained formulation showed good stability in physiological condition and preparation media up to 1 month. Temozolomide loaded inside the carrier exhibited greater stability than the free drug, in particular in simulated physiological solution at pH 7.4 where the hydrolysis in the inactive metabolite was clearly delayed. CS-SPLA nanoparticles demonstrated a pH-dependent TMZ release kinetics with the opportunity to increase or decrease the rate. Mass spectroscopy, UV-Vis analysis, and in vitro cell tests confirmed the improvement in temozolomide stability and effectiveness when loaded into the polymeric carrier, in comparison with the free drug.

KW - Chitosan

KW - Drug delivery

KW - Encapsulation

KW - Nanomedicine

KW - Nanoparticles

KW - Polylactic acid

KW - Temozolomide

UR - http://www.scopus.com/inward/record.url?scp=85013324745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013324745&partnerID=8YFLogxK

U2 - 10.1007/s11051-017-3756-3

DO - 10.1007/s11051-017-3756-3

M3 - Article

VL - 19

JO - Journal of Nanoparticle Research

JF - Journal of Nanoparticle Research

SN - 1388-0764

IS - 2

M1 - 71

ER -